scholarly journals Behavioral, Biochemical and Electrophysiological Changes in Spared Nerve Injury Model of Neuropathic Pain

2020 ◽  
Vol 21 (9) ◽  
pp. 3396 ◽  
Author(s):  
Francesca Guida ◽  
Danilo De Gregorio ◽  
Enza Palazzo ◽  
Flavia Ricciardi ◽  
Serena Boccella ◽  
...  

Neuropathic pain is a pathological condition induced by a lesion or disease affecting the somatosensory system, with symptoms like allodynia and hyperalgesia. It has a multifaceted pathogenesis as it implicates several molecular signaling pathways involving peripheral and central nervous systems. Affective and cognitive dysfunctions have been reported as comorbidities of neuropathic pain states, supporting the notion that pain and mood disorders share some common pathogenetic mechanisms. The understanding of these pathophysiological mechanisms requires the development of animal models mimicking, as far as possible, clinical neuropathic pain symptoms. Among them, the Spared Nerve Injury (SNI) model has been largely characterized in terms of behavioral and functional alterations. This model is associated with changes in neuronal firing activity at spinal and supraspinal levels, and induces late neuropsychiatric disorders (such as anxious-like and depressive-like behaviors, and cognitive impairments) comparable to an advanced phase of neuropathy. The goal of this review is to summarize current findings in preclinical research, employing the SNI model as a tool for identifying pathophysiological mechanisms of neuropathic pain and testing pharmacological agent.

Neuroreport ◽  
2013 ◽  
Vol 24 (3) ◽  
pp. 131-136 ◽  
Author(s):  
Jun Zhou ◽  
Cheng-Xiang Yang ◽  
Ji-Ying Zhong ◽  
Han-Bing Wang

Pain ◽  
2002 ◽  
Vol 98 (1) ◽  
pp. 151-161 ◽  
Author(s):  
Helle Kirstein Erichsen ◽  
Gordon Blackburn-Munro

Molecules ◽  
2020 ◽  
Vol 25 (5) ◽  
pp. 1171 ◽  
Author(s):  
Paramita Basu ◽  
Arpita Basu

Neuropathic pain is a common symptom and is associated with an impaired quality of life. It is caused by the lesion or disease of the somatosensory system. Neuropathic pain syndromes can be subdivided into two categories: central and peripheral neuropathic pain. The present review highlights the peripheral neuropathic models, including spared nerve injury, spinal nerve ligation, partial sciatic nerve injury, diabetes-induced neuropathy, chemotherapy-induced neuropathy, chronic constriction injury, and related conditions. The drugs which are currently used to attenuate peripheral neuropathy, such as antidepressants, anticonvulsants, baclofen, and clonidine, are associated with adverse side effects. These negative side effects necessitate the investigation of alternative therapeutics for treating neuropathic pain conditions. Flavonoids have been reported to alleviate neuropathic pain in murine models. The present review elucidates that several flavonoids attenuate different peripheral neuropathic pain conditions at behavioral, electrophysiological, biochemical and molecular biological levels in different murine models. Therefore, the flavonoids hold future promise and can be effectively used in treating or mitigating peripheral neuropathic conditions. Thus, future studies should focus on the structure-activity relationships among different categories of flavonoids and develop therapeutic products that enhance their antineuropathic effects.


Sign in / Sign up

Export Citation Format

Share Document